US Investment bank repeats ‘buy’ and US$8 price target on Tiziana Life Sciences
Earlier this week Zacks Small-Cap Research reiterated its US$7.50 valuation of the stock – more than triple the…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.